Vita Golubovskaya Medicine Promab Biotechnologies; Health Sciences Center, Oklahoma University Biography Publications Institution JoVE Articles Vita GolubovskayaDirector Research and Development; Volunteer Clinical Associate Professor Dr. Vita Golubovskaya is a Director of Research and Business Development at Promab Biotechnologies leading research of novel anti-cancer immunotherapies including CAR-T cell therapy. She has more than 20 years of experience in cancer research, oncology and immunology. Previously, Dr. Golubovskaya was a Research Associate Professor at Roswell Park Cancer Institute and Research Professor at University of Buffalo, SUNY, Buffalo, NY. She holds Ph.D in Cell Biology from Institute of Cytology, St. Petersburg, Russia. Dr. Golubovskaya authored more than 80 publications, 20 patents and several book chapters. She was awarded Susan Komen Grant for Breast Cancer, NCI NIH and STTR grants. Dr. Golubovskaya served as a Guest Editor in Frontiers in Bioscience, Anti-Cancer Agents in Medicinal Chemistry and Cancers. She is an Active Member of AACR. Publications En potens-analys i real tid för chimeric antigen receptor T-celler riktade mot solida och hematologiska cancer celler Biao Xi1, Robert Berahovich2, Hua Zhou2, Shirley Xu2, Yuehua Wei2, Jasper Guan2, Hizkia Harto2, Jian Guan2, Lijun Wu2, David Santa Ana1,3, Fabio Cerignoil1, Brandon Lamarche1, Yama A. Abassi1, Vita Golubovskaya2 1ACEA Biosciences, Inc, 2ProMab Biotechnologies. Inc, 3ACEA Therapeutics JoVE 59033 Immunology and Infection
En potens-analys i real tid för chimeric antigen receptor T-celler riktade mot solida och hematologiska cancer celler Biao Xi1, Robert Berahovich2, Hua Zhou2, Shirley Xu2, Yuehua Wei2, Jasper Guan2, Hizkia Harto2, Jian Guan2, Lijun Wu2, David Santa Ana1,3, Fabio Cerignoil1, Brandon Lamarche1, Yama A. Abassi1, Vita Golubovskaya2 1ACEA Biosciences, Inc, 2ProMab Biotechnologies. Inc, 3ACEA Therapeutics JoVE 59033 Immunology and Infection
